3634
M. A. Haidekker et al. / Bioorg. Med. Chem. 10 (2002) 3627–3636
6.88 (2H, d, J =8.8), 6.21 (1H, t, J =5.2), 5.04 (2H, s),
3.80 (3H, s), 3.36 (2H, q, J =6.8), 3.31 (4H, t, J =6.0),
2.74 (4H, t, J =7.6), 2.34 (2H, t, J=7.6), 1.95 (4H, m),
1.70–1.54 (4H, m) 1.38 (2H, m); 13C NMR (100 MHz,
CDCl3) 173.1, 162.2, 159.3, 152.1, 146.8, 130.8, 130.0,
128.0, 120.5, 119.4, 118.4, 113.8, 93.2, 65.9, 55.3, 50.1,
40.1, 34.2, 29.4, 27.6, 26.4, 24.6, 21.2; HRMS, calcd for
C30H35N3O4 (M+Cs+) 634.1678, found 634.1693.
CDCl3) d 7.97 (1H, s), 7.42 (2H, s), 6.44 (1H, t, J =5.6),
5.21–5.19 (IH, m), 4.38–4.23 (3H, m), 4.15–4.10 (1H,
m), 3.98 (2H, t, J =6.4), 3.83 (2H, s), 3.38 (11H, s), 3.29
(4H, t, J=5.6), 2.73 (4H, t, J=6.4), 2.34–2.25 (4H, m),
1.97–1.91 (4H, m), 1.65–1.52 (4H, m), 1.4–1.35 (2H, m),
1.23 (16H, s), 0.86 (3H, t, J =6.8); 13C NMR (100 MHz,
CDCl3) d 173.3, 172.7, 162.3, 152.9, 146.8, 130.8, 120.5,
119.3, 118.4, 93.4, 70.6, 70.4, 66.3, 63.5, 62.9, 59.3, 54.5,
50.1, 40.1, 34.1, 32.0, 29.7, 29.7, 29.6, 29.4, 29.4,
29.3,29.2, 27.7, 26.4, 26.3, 24.9, 24.6, 22.7, 21.3, 14.2;
HRMS m/z calcd for C42H67N4O9P (M+H+) 803.4718,
found 803.4682.
Ester 17. Preparation of this compound was accom-
plished in 72% yield following the procedure described
above for the synthesis of compound 16. 17: yellow
solid; IR (film) nmax 3054, 2986, 2305, 2197, 1730, 1666,
1
1516; H NMR (400 MHz, CDCl3) d 8.00 (1H, s), 7.42
Phospholipid 23. Preparation of this compound was
accomplished following the procedure described above
for the synthesis of compound 22. 23: IR (film) nmax
3377, 2924, 2852, 2200, 1735, 1664; 1H NMR (400 MHz,
CDCl3) d 7.95 (1H, s), 7.42 (2H, s), 6.44 (1H, t, J=5.6),
5.20–5.17 (1H, m), 4.38–4.34 (3H, m), 4.15–4.10 (1H,
m), 3.98 (2H, t, J =6.4), 3.84 (2H, s), 3.38 (11H, s), 3.29
(4H, t, J=5.6), 2.73 (4H, t, J=6.4), 2.34–2.25 (4H, m),
1.97–1.91 (4H, m), 1.65–1.52 (4H, m), 1.4–1.35 (2H, m),
1.23 (26H, s), 0.86 (3H, t, J =6.8); 13C NMR (100 MHz,
CDCl3) d 173.3, 172.7, 162.3, 152.9, 146.8, 130.8, 120.5,
119.3, 118.2, 93.4, 70.6, 70.5, 66.3, 63.6, 62.8, 59.4, 54.4,
50.1, 40.1, 34.1, 32.0, 29.7, 29.6, 29.4, 29.3, 29.2, 27.6,
26.3, 24.9, 24.6, 22.7, 21.2, 14.2; HRMS m/z calcd for
C46H75N4O9P (M+H+) 859.3544, found 859.5322.
(2H, s), 7.28 (2H, s), 6.88 (2H, d, J =8.4), 6.22 (1H, s),
5.03 (2H, s), 3.78 (3H, s), 3.37 (2H, q, J =6.8), 3.29
(4H, t, J=5.6), 2.73 (4H, t, J =6.0), 2.39 (2H, t,
J=7.2), 1.94 (4H, m), 1.62–1.56 (4H, m), 1.25 (12H, s);
13C NMR (100MHz, CDCl3) d 173.6, 162.3, 159.4, 152.1,
146.8; 130.8 129.9, 128.2, 120.6, 119.4, 118.5, 113.8, 113.7,
93.4, 65.7, 55.2, 49.9, 40.27, 34.3, 29.5, 29.31, 29.26, 29.2,
29.1, 29.0, 27.5, 26.8, 24.9, 21.1; HRMS, calcd for
C35H45N3O4 (M+H+) 572.3487, found 572.3491.
Acid 18. 2.2 g of ester 16 (4.4 mmol) were dissolved in
10 mL of a 4:1 mixture of trifluoroacetic acid and ani-
sole and stirred at 25 ꢀC for 10 min. The solvents were
initially removed under reduced pressure, and sub-
sequently azeotropically removed using benzene (3Â10
mL). The residue was then chromatographed (silica, 0–
10% methanol in dichloromethane) to produce 1.5 g of
carboxylic acid 18 (3.9 mmol, 59%). 18: red solid; IR
Phospholipid 24. Preparation of this compound was
accomplished in 48% yield following the procedure
described above for the synthesis of compound 22. 24:
1
1
(film) nmax 2199, 1720, 1647, 1515; H NMR (400 MHz,
red solid; H NMR (400 MHz, CDCl3) d 7.98 (1H, s),
DMSO-d6) d 7.94 (1H, t, J=5.6), 7.77 (1H, s), 7.40 (2H,
s), 3.27 (4H, m), 3.15 (2H, m), 2.66 (4H, m), 2.19 (2H, t,
J =7.6), 1.85 (4H, m, J =5.6), 1.48 (4H, m), 1.26 (2H,
m); 13C NMR (100 MHz, DMSO-d6) d 174.4, 162.2,
150.0, 146.4, 130.1, 120.3, 118.5, 117.7, 94.9, 49.3, 33.6,
28.8, 27.1, 25.9, 24.2, 20.7; HRMS, calcd for
C22H27N3O3 (M+C+) 514.1103, found 514.1130.
7.41 (2H, s), 6.22 (1H, t, J=5.2), 5.17 (1H, m), 4.38–
4.28 (3H, m), 4.12–4.08 (1H, m), 3.93 (2H, d, J=6.0),
3.78 (2H, s), 3.37 (11H, s), 4.29 (4H, t, J=5.2), 2.72
(4H, t, J=6.0), 2.28–2.23 (5H, m), 1.96–1.90 (4H, m),
1.55 (7H, s), 1.23 (40H, s), 0.85 (3H, t, J=6.4); 13C
NMR (100 MHz, CDCl3) d 173.4, 173.1, 162.0, 152.1,
146,87, 130.9, 120.6, 119.4, 118.6, 93.5, 70.5, 70.4, 66.3,
63.3, 62.9, 59.2, 54.4, 50.0, 40.3, 34.3, 34.1, 31.9, 29.7,
29.6, 29.6, 29.5, 29.4, 29.4, 29.3, 29.3, 29.2, 29.1, 29.1,
27.6, 26.9, 24.9, 24.8, 22.6, 21.2, 14.1; HRMS m/z calcd
for C51H85N4O9P (M+H+) 929.4327, found 929.4339.
Acid 19. Preparation of this compound was accom-
plished following the procedure described above for the
1
synthesis of compound 18. 19: brown solid; 73%; H
NMR (400 MHz, CDCl3) d 8.02 (1H, s), 7.44 (2H, s),
6.27 (1H, t, J=5.6), 3.45 (4H, m), 3.29 (2H, m), 2.83
(4H, t, J =6.4), 2.43 (2H, t, J =7.6) 2.04 (4H, t, J =6),
1.64–1.53 (4H, m), 1.28 (12H, s); 13C NMR (100 MHz,
CDCl3) d 179.0, 162.5, 152.3, 146.9, 130.9, 120.6, 119.5,
118.5, 93.2, 50.0, 40.3, 33.9, 29.5, 29.2, 29.3, 29.1, 29.1,
28.9, 27.6, 26.8, 24.6, 21.2; HRMS, calcd for
C27H37N3O3 (M+Cs+) 584.1886, found 584.1899.
Compound 28. To a solution of 51 mg cyano acetic
p-nitro phenolate (0.25 mmol) in 0.5 mL CDCl3, was
added 160 mg (0.25 mmol) dimyristoyl-l-a-phosphati-
dyl ethanolamine (C14:0) and 31 mg (0.25 mmol)
DMAP and the reaction was stirred at 25 ꢀC for 12 h.
The solvent was then removed under reduced pressure
and the residue was dissolved in THF (1.5 mL) and
treated with 42 mg of DBU (0.25 mmol) and 52 mg of
aldehyde 15 (0.28 mmol). The reaction mixture was
stirred at 50 ꢀC for 12 h. The solvent was removed under
reduced pressure and the residue was purified on silica
(0–8% methanol in dichloromethane) to yield 85 mg of
phospholipid 28 (38%). 28: bright yellow liquid; IR
(film) nmax 3370, 2923, 2852, 2201, 1738, 1516; 1H NMR
(400 MHz, CD3OD) d 7.76 (1H, s), 7.34 (2H, s), 5.10
(1H, m), 4.38–4.28 (1H, m), 4.10–4.02 (1H, m), 3.90–
3.79 (3H, m), 3.21–3.09 (4H, m), 2.63–2.56 (4H, m), 1.91
(2H, m, J=5.6), 1.84 (2H, m, J=6.0), 1.70–1.41 (12H,
Phospholipid 22. To a solution of 138 mg of acid 18
(0.33 mmol) in 3 mL of chloroform were added 107 mg
of lysophospholipid 20 (0.33 mmol), 64 mg of EDC
(0.33 mmol), and 40 mg of DMAP (0.33 mmol) and the
reaction was stirred for 18 h at 25 ꢀC. The solvent was
removed under reduced pressure and the resulting resi-
due was purified by reversed phase flash chromato-
graphy (0–100% acetonitrile/water) to give 157 mg of
phospholipid 22 (54%). 22: red liquid; IR (film) nmax
3377, 2924, 2852, 2200, 1735, 1664; 1H NMR (400 MHz,